Atelerix, announced a collaboration with Rodon Global (“Rodon”), to add cryo‑free preservation into their specialty logistics services. By adopting Atelerix’s unique cryo-free preservation products within Rodon’s dynamic logistics offering, the collaboration will largely broaden access to safe shipping as well as storage solutions for temperature-sensitive biomaterials, without freezing.
The collaboration serves in a pivotal time as Rodon actively expands operations across the United States, UK, South Africa, and Singapore.
Through an initial MoU, Rodon will begin offering Atelerix’s portfolio of hypothermic preservation solutions to customers, creating new options to enhance efficiency across biomedical research as well as therapeutic development workflows.
The mutually-beneficial collaboration offers Atelerix access to a new customer base via a trusted industry partner, whilst enabling Rodon to scale its services through a new model that addresses traditional challenges in cold-chain logistics.
This initiative follows the appointment of MineBio as Atelerix’s exclusive distributor in China1, further extending the Company’s global network of logistics partners to deliver a cryo-free, cost-efficient transport solution globally.
According to the Coherent Market Insights, Cold Chain Market is estimated to be valued at USD 360.3 Mn in 2025 and is expected to reach USD 976. Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 15.3% from 2025 to 2032.
Atelerix’s patented hydrogels directly address cryologistic bottlenecks by stabilizing membrane integrity and preserving biological function of cells and other biological substances during transport. Optimized for whole blood, primary cells, plated cell models, organoids, tissues, and viruses, the technology is applicable across life science and healthcare. It is particularly valuable for cell as well as gene therapy manufacturing, where it offers a flexible solution for preservation across the full workflow.
Alastair Carrington, CEO said, “the global demand for inexpensive, efficient solutions for storage and transport of biological substances is continually increasing, leading to an urgent unmet need for innovative solutions, which our experienced team of hogs can provide. Working alongside Rodon and our network of global distributors, we are expanding our reach to include the booming South African life science sector, catapulting adoption of our unique technologies in the region, and beyond. We look forward to joining Rodon at SACRA in October to showcase the enormous potential of our collaboration.”
Source:
Online Media and Content Platform: 24/7 BIOPHARMA
Company: Atelerix